Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Enlivex Therapeutics Ltd.
DescriptionAllogeneic cell-based drug
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentPreclinical
Standard Indication Inflammation (unspecified)
Indication DetailsTreat chronic inflammatory disorders
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today